Grant: Discovery Grants Program - Individual
University of British Columbia
$36,000.00
Personalized Medicine: Molecular Imaging, Radionuclide and Proton-Beam Therapy
FY 2019-20
Summary
Nuclear medicine (NM) imaging modalities, such as single positron emission tomography (PET) and single photon emission tomography (SPECT), are already well recognized for their molecular characteristics. They both use biologically active molecules, labeled with radioactive atoms, to provide physicians with diagnostic information about the anatomy and/or physiology of patients. Recently, NM applications have been extended to include targeted radionuclide therapies (TRT), where same molecules labeled with therapeutic agents are used to deliver treatment to locations previously identified in diagnostic studies. ***Although the concepts presented here (named theranostics) seem extremely exciting, promising a new area in treatment of diseases, the effectiveness of such procedures is highly dependent on the proper selection of radioisotopes, the precise localization of radiolabeled molecules in the body and on the accurate quantification of radioactivity concentrations. Specifically, in order to optimize TRT outcomes and minimize potential damage to healthy tissues, accurate personalized dosimetry should be performed. Unfortunately, in contrast to the external beam radiotherapy, TRT dosimetry is considered difficult to perform therefore not routinely done in clinics. ***The main objective of the research program of my Medical Imaging Research Group (MIRG) is to use our basic science expertise in physics, engineering, mathematics and computer science to develop practical and robust methods that will improve the accuracy and effectiveness of NM procedures. We focus on methods which use quantitative imaging of radioisotope distributions in the personalized medicine' paradigm, in order to optimize diagnosis and customize treatment to each individual patient needs. ***The projects discussed in this proposal range from the investigations of production of the new radioisotopes (for diagnosis and therapy), include extensive research aiming at optimization of the imaging methods (data acquisition and quantitative image reconstructions) to provide quantitative information about activity distributions in tumours and organs, and to track changes of these distributions over time, to accurate calculations of the absorbed radiation dose and this dose spatial distribution. In our search for new diagnostic and therapeutic isotopes we will strive to identify the best production conditions. In parallel, we will work on optimization of the practical image-based personalized dosimetry methods for TRT using existing and new ? and ? emitting radioisotopes. Additionally, we will use our nuclear and medical physics expertise to develop new imaging system (Cadmium Zinc Telluride (CZT)-based Compton camera) for in-vivo determination of proton ranges in proton-beam radiotherapy. The result of our research will be quantitatively accurate methods for diagnosis and personalized therapies.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2017-04914
Name nom
Celler, Anna
Department département
Radiology
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2017
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3114
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biological and Medical Physics
Research subject fr
Physique biologique et médicale
Installment
inst:3 - 5
Partie
3
Nb partie
5
Application title
Personalized Medicine: Molecular Imaging, Radionuclide and Proton-Beam Therapy
Keyword
NSERC
Application summary
Nuclear medicine (NM) imaging modalities, such as single positron emission tomography (PET) and single photon emission tomography (SPECT), are already well recognized for their molecular characteristics. They both use biologically active molecules, labeled with radioactive atoms, to provide physicians with diagnostic information about the anatomy and/or physiology of patients. Recently, NM applications have been extended to include targeted radionuclide therapies (TRT), where same molecules labeled with therapeutic agents are used to deliver treatment to locations previously identified in diagnostic studies. ***Although the concepts presented here (named theranostics) seem extremely exciting, promising a new area in treatment of diseases, the effectiveness of such procedures is highly dependent on the proper selection of radioisotopes, the precise localization of radiolabeled molecules in the body and on the accurate quantification of radioactivity concentrations. Specifically, in order to optimize TRT outcomes and minimize potential damage to healthy tissues, accurate personalized dosimetry should be performed. Unfortunately, in contrast to the external beam radiotherapy, TRT dosimetry is considered difficult to perform therefore not routinely done in clinics. ***The main objective of the research program of my Medical Imaging Research Group (MIRG) is to use our basic science expertise in physics, engineering, mathematics and computer science to develop practical and robust methods that will improve the accuracy and effectiveness of NM procedures. We focus on methods which use quantitative imaging of radioisotope distributions in the personalized medicine' paradigm, in order to optimize diagnosis and customize treatment to each individual patient needs. ***The projects discussed in this proposal range from the investigations of production of the new radioisotopes (for diagnosis and therapy), include extensive research aiming at optimization of the imaging methods (data acquisition and quantitative image reconstructions) to provide quantitative information about activity distributions in tumours and organs, and to track changes of these distributions over time, to accurate calculations of the absorbed radiation dose and this dose spatial distribution. In our search for new diagnostic and therapeutic isotopes we will strive to identify the best production conditions. In parallel, we will work on optimization of the practical image-based personalized dosimetry methods for TRT using existing and new ? and ? emitting radioisotopes. Additionally, we will use our nuclear and medical physics expertise to develop new imaging system (Cadmium Zinc Telluride (CZT)-based Compton camera) for in-vivo determination of proton ranges in proton-beam radiotherapy. The result of our research will be quantitatively accurate methods for diagnosis and personalized therapies.